Safety and efficacy of abatacept in patients with treatment-resistant SARCoidosis (ABASARC) – protocol for a multi-center, single-arm phase IIa trial

INTRODUCTION: Sarcoidosis is a granulomatous systemic disease that becomes chronic in approximately one third of affected patients resulting in quality of life and functional impairment. Immunosuppressive drugs other than steroids represent alternative therapeutic options, but side effects like live...

Descripción completa

Detalles Bibliográficos
Autores principales: Frye, Björn C., Rump, Ina Caroline, Uhlmann, Annette, Schubach, Fabian, Ihorst, Gabriele, Grimbacher, Bodo, Zissel, Gernot, Quernheim, Joachim Müller
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292904/
https://www.ncbi.nlm.nih.gov/pubmed/32551397
http://dx.doi.org/10.1016/j.conctc.2020.100575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292904/
https://www.ncbi.nlm.nih.gov/pubmed/32551397
http://dx.doi.org/10.1016/j.conctc.2020.100575

Ejemplares similares